205526-40-5,
Fmoc-D-2-indanylglycine,
Fmoc-D-Igl-OH,
(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(2,3-dihydro-1H-inden-2-yl)acetic acid,
SCHEMBL800168,
CTK8E9975,
DTXSID80660702,
ZINC2569522,
6953AD,
Fmoc-D-2-indanylglycine, AldrichCPR,
MFCD00797587,
AKOS025312275,
RTR-009605,
ACM205526405,
TR-009605,
FT-0679762,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-2-indanylglycine,
(2R)-(2,3-Dihydro-1H-inden-2-yl)({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)acetic acid,
(R)-2,3-dihydro-1H-inden-2-yl({[(9H-fluoren-9-ylmethoxy)carbonyl]amino})acetic acid,
1H-Indene-2-aceticacid,a-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,3-dihydro-,(ar)-,
1H-Indene-2-acetic acid, alpha-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,3-dihydro-, (alphaR)-,
C26H23NO4,